Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

ResMed Announces New iPhone App

May 24, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 24, 2011 /- ResMed (NYSE: RMD ) today released the ResMed Sleep Assessment app, a novel new app for iPhone that lets users record themselves during sleep. The app also includes a clinically validated questionnaire that assesses their risk and other helpful features to...

Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment

May 24, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif. and AUCKLAND, New Zealand, May 24, 2011 /- Centella Therapeutics, Inc., a subsidiary of Varian Medical Systems, Inc. (NYSE: VAR ), and Auckland UniServices Ltd. of Auckland, New Zealand, today announced that they have entered into a licensing agreement granting Centella...

Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis

May 24, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis...

Advertisement

Pacira Pharmaceuticals, Inc. Announces EXPARELâ„¢ Data Presentations at the International Anesthesia Research Society 2011 Annual Meeting

May 23, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., May 23, 2011 /- Pacira Pharmaceuticals, Inc., (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced that clinical data highlighting the safety profile of EXPAREL™ (bupivacaine extended-release liposome injection) will be presented at the...

Mylan Launches Generic Version of Depakote® Sprinkle Capsules

May 23, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, May 23, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Divalproex Sodium Capsules USP, 125 mg, the generic version of Abbott's Depakote® Sprinkle Capsules, a treatment for certain types of seizures.  ...

A Nightshirt to Monitor Sleep

May 22, 2011 8:33 pm | by Massachusetts Institute of Technology | News | Comments

A newly developed smart shirt detects the wearer's stage of sleep via respiration patterns.

Infinity Pharma: One cancer drug advances, one ends development

May 19, 2011 10:42 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Infinity Pharmaceuticals Inc. is launching a Phase 2 trial of its potential treatment for non-small cell lung cancer, retaspimycin HCl in combination with the approved chemotherapy drug, Taxotere, marketed by French drug maker Sanofi.

Families of Spinal Muscular Atrophy Announces Repligen Corporation Receives FDA Approval to Begin Phase I Clinical Trial in SMA

May 19, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

CHICAGO, May 19, 2011 /PRNewswire-USNewswire/ -- Families of Spinal Muscular Atrophy announced today that Repligen Corporation has received approval from the U.S. Food and Drug Administration to commence a Phase I safety study in healthy volunteers for RG3039, formerly called...

Advertisement

Takeda to Acquire Nycomed

May 18, 2011 11:37 pm | by Bio-Medicine.Org | News | Comments

OSAKA, Japan, and ZURICH, May 19, 2011 /- Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) and Nycomed A/S ("Nycomed") jointly announced today that Takeda has reached an agreement with the shareholders of Nycomed in which Takeda will acquire the Zurich-headquartered company for...

Pearl Therapeutics' Phase 2b Results Show a 50% Improvement in Lung Function with PT003 Compared to Spiriva® and Foradil® in Patients with COPD

May 18, 2011 9:41 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., May 18, 2011 /- Pearl Therapeutics Inc. presented detailed efficacy and safety results today from the Company's phase 2b study of PT003  (GFF MDI) in patients with moderate-to-very severe COPD during a late-breaker poster session at the annual meeting of the...

ARX-01 and ARX-03 Clinical Results Presented at the 30th Annual Scientific Meeting of the American Pain Society

May 18, 2011 9:41 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., May 18, 2011 /- AcelRx Pharmaceuticals, Inc. announced today that the results from its Phase 2 clinical studies related to two product candidates, ARX-01 Sufentanil NanoTab(R) PCA System, which is designed to solve the problems associated with post-operative...

Maine Medical Equipment Providers Back Congressional Bill to Repeal Flawed Medicare Bidding Program

May 16, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

PORTLAND, Maine, May 16, 2011 /PRNewswire-USNewswire/ -- Maine home medical equipment and services (HME) providers support H.R. 1041, a bipartisan bill in Congress to repeal the controversial Medicare "competitive" bidding program for home medical equipment and services.   "If...

Massachusetts Home Medical Equipment Providers Back Federal Legislation to Repeal Controversial Medicare Bidding Program

May 16, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

BOSTON, May 16, 2011 /PRNewswire-USNewswire/ -- Massachusetts providers of home medical equipment and services (HME) support H.R. 1041, a bipartisan bill in Congress to repeal the flawed, controversial Medicare "competitive" bidding program for medically required equipment and services....

Advertisement

Lilly Oncology to Unveil Data From More Than 30 Studies at ASCO

May 16, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, May 16, 2011 /- Eli Lilly and Company (NYSE: LLY ) will present data from more than 30 studies at the 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill., from June 3 – 7, 2011, including results from PARAMOUNT, a Phase III study of...

MedImmune To Present Eight Abstracts on Projects Regarding Thoracic and Respiratory Issues at the Annual American Thoracic Society International Conference

May 13, 2011 6:39 am | by Bio-Medicine.Org | News | Comments

GAITHERSBURG, Md., May 13, 2011 /- MedImmune announced today it will present eight abstracts at the American Thoracic Society (ATS) International Conference in Denver, CO, May 13-18, 2011.  "These data advance our understanding of thoracic diseases, highlighting our continued...

Mylan Launches Generic Version of Risperdal® M-Tab®

May 13, 2011 4:47 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, May 13, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Risperidone Orally Disintegrating Tablets (ODT), 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg, the generic version of Ortho-McNeil's Risperdal® M-Tab®, a...

Amira Pharmaceuticals to Present Preclinical Data on AM152 , an LPA1 Receptor Antagonist, at the Annual Meeting of the American Thoracic Society

May 11, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 11, 2011 /- Amira Pharmaceuticals, Inc. announced today that it will present preclinical data on AM152, an LPA1 receptor antagonist, during the Annual Meeting of the American Thoracic Society (ATS) in Denver, Colorado.  The poster, titled "The LPA1 Antagonist, AM152,...

Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation

May 10, 2011 5:34 am | by Boston Scientific | News | Comments

Company sponsors additional efforts to promote education and awareness of severe asthma

Insmed Announces First Quarter 2011 Financial Results

May 10, 2011 4:32 am | by Bio-Medicine.Org | News | Comments

MONMOUTH JUNCTION, N.J., May 10, 2011 /- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today reported results for the first quarter ended March 31, 2011. Key Recent Highlights: Received Food and Drug Administration (FDA) clearance of Investigational New Drug (IND)...

Huntsville Memorial Hospital Selects Surgical Information Systems to Increase Safety, Generate Cost Savings

May 10, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

ATLANTA, May 10, 2011 /- Surgical Information Systems ("SIS") announced today that Huntsville Memorial Hospital in Huntsville, TX, selected SIS' surgical solution to automate its perioperative department, interfacing with the hospital's current MEDITECH system to provide patient care...

Generex Biotechnology Corporation CEO Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com

May 9, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, May 9, 2011 /- Generex Biotechnology Corporation ( www.generex.com ) (OTC:GNBT) announced that their May 5th RetailInvestorConferences.com presentation is available for on-demand viewing. LINK: www.retailinvestorconferences.com >Click the red "register/ watch event now"...

Former NBA Star Allan Houston Joins "Apply Yourself!" Campaign to Raise Awareness of Osteoarthritis Hand and Knee Pain

May 9, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

CHADDS FORD, Pa., May 9, 2011 /- Endo Pharmaceuticals, a leading healthcare solutions company, today announced the launch of the "Apply Yourself!" Campaign, created to encourage people suffering from osteoarthritis (OA) hand and knee pain to make pain relief a top personal priority....

Acton Pharma names Newman, Phair as new execs

May 6, 2011 11:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Acton Pharmaceuticals Inc., a respiratory therapeutics firm in Marlborough, has appointed two new executives in naming Kenneth Newman as executive vice president, chief medical officer, and Thomas Phair as senior vice president, chief financial officer.

American Regent Initiates Nationwide Voluntary Recall of Caffeine & Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial Due to Visible Particulates

May 5, 2011 2:32 pm | by Bio-Medicine.Org | News | Comments

SHIRLEY, N.Y., May 5, 2011 /- American Regent is conducting a nationwide voluntary recall to the consumer and user level of the following product: Caffeine & Sodium Benzoate Injection, USP, 250 mg/mL, 2 mL Single Dose Vial, NDC # 0517-2502-10, Lot # 0084,  Exp Date...

Power Wheelchairs Keep Medicare Beneficiaries Out of Nursing Homes, While Reducing Government Costs and Providing More Freedom and Independence

May 5, 2011 2:32 pm | by Bio-Medicine.Org | News | Comments

OCEANSIDE, Calif., May 5, 2011 /PRNewswire-USNewswire/ -- For Judith Talnadge, a power wheelchair provided through Medicare is the difference between living independently in her apartment, with opportunities to visit with friends and engage in the community, or being confined to a nursing...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading